Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Masato Kawasaki

Osaka General Medical Center, Osaka (Japan)

8 More presentations in this session

Presentation thumbnail

Prediction of ventricular tachyarrhythmias occurrence by changes in physiological parameters derived from implantable-cardioverter defibrillators

Doctor N. Chan (Hong Kong, HK)

Abstract Slides

Presentation thumbnail

An evaluation of the effect of the subcutaneous implantable defibrillator smartpass filter on inappropriate shock reduction.

Doctor T. Brouwer (Amsterdam, NL)

Presentation thumbnail

The effectiveness of the wearable cardioverter defibrillator in a real world environment

Doctor C. Abrahim (Springfield, US)

Abstract Slides

Presentation thumbnail

Sudden cardiac arrest in patients with cardiac implantable electronic devices

Doctor A. Sharifzadehgan (Paris, FR)

Presentation thumbnail

Implantable cardioverter-defibrillator therapy in patients presenting with acute coronary syndromes - useful before 40 days?

Doctor J. Ferreira (Coimbra, PT)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Session

Ventricular storm (2)

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources